Explore Moderna's growth potential with FDA-approved respiratory vaccines, strong cash reserves, and a robust pipeline.

This stock used to be a highflyer but has struggled in recent years as demand waned for its flagship product. Though Moderna ...

It’s easy to get caught up in a rally, especially when the S&P 500 keeps pushing and tech stocks feel revitalized. However, in a bull run, there are always weak links. 💵💰Don't miss the move: ...

What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 3.6% in the morning session after JPMorgan added ...

Sioux City put a damper on Cleburne’s series-winning streak as the Railroaders dropped all three games to the Explorers over ...

Moderna’s COVID-19 vaccine has received full FDA approval for use in children at higher risk for severe illness.

The average short interest for the S&P 500 Health Care Index Sector (NYSEARCA:XLV) experienced an increase in June, moving ...